Bowhead Specialty Holdings (BOW) Cash & Equivalents (2022 - 2026)

Bowhead Specialty Holdings has disclosed Cash & Equivalents across 5 years of filings, most recently posting $97.2 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $97.2 million, up 10.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $97.2 million (up 10.37% YoY), and the FY2025 annual result was $193.5 million, up 98.56% from the prior year.
• Cash & Equivalents came in at $97.2 million for Q1 2026 at Bowhead Specialty Holdings, down from $193.5 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $197.9 million in Q3 2025 to a low of $64.7 million in Q4 2022.
• The 5-year median for Cash & Equivalents is $114.8 million (2025), against an average of $119.8 million.
• Across the five-year window, Cash & Equivalents jumped 148.3% in 2024 and plunged 36.33% in 2025, its largest moves.
• Bowhead Specialty Holdings' Cash & Equivalents stood at $64.7 million in 2022, then jumped by 82.6% to $118.1 million in 2023, then declined by 17.44% to $97.5 million in 2024, then jumped by 98.56% to $193.5 million in 2025, then plunged by 49.79% to $97.2 million in 2026.
• The last three Cash & Equivalents figures came in at $97.2 million (Q1 2026), $193.5 million (Q4 2025), and $197.9 million (Q3 2025), per Business Quant data.